Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
12
2020
accepted:
15
07
2021
entrez:
11
8
2021
pubmed:
12
8
2021
medline:
24
8
2021
Statut:
epublish
Résumé
Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited testing policies to confirm SARS-CoV-2 infection. Recently, it was shown that it is possible to predict COVID-19 cases using cross-sectional self-reported disease-related symptoms. Here, we demonstrate that this COVID-19 prediction model has reasonable and consistent performance across multiple independent cohorts and that our attempt to improve upon this model did not result in improved predictions. Using the existing COVID-19 prediction model, we then conducted a GWAS on the predicted phenotype using a total of 1,865 predicted cases and 29,174 controls. While we did not find any common, large-effect variants that reached genome-wide significance, we do observe suggestive genetic associations at two SNPs (rs11844522, p = 1.9x10-7; rs5798227, p = 2.2x10-7). Explorative analyses furthermore suggest that genetic variants associated with other viral infectious diseases do not overlap with COVID-19 susceptibility and that severity of COVID-19 may have a different genetic architecture compared to COVID-19 susceptibility. This study represents a first effort that uses a symptom-based predicted phenotype as a proxy for COVID-19 in our pursuit of understanding the genetic susceptibility of the disease. We conclude that the inclusion of symptom-based predicted cases could be a useful strategy in a scenario of limited testing, either during the current COVID-19 pandemic or any future viral outbreak.
Identifiants
pubmed: 34379666
doi: 10.1371/journal.pone.0255402
pii: PONE-D-20-38159
pmc: PMC8357137
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255402Subventions
Organisme : European Research Council
Pays : International
Organisme : EPA
ID : EP-C-15-001
Pays : United States
Organisme : Wellcome Trust
ID : 216767/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 194036/Z/14
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have read the journal’s policy and have the following competing interests: ETC, KMSB, SR, AB, SW, FT, XW, JMR, YWL, JTL, and NLW are employees of Helix OpCo, LLC, which is a provider of COVID-19 testing services. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
BMJ Open. 2021 Mar 17;11(3):e044474
pubmed: 33737436
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Bioinformatics. 2018 Apr 1;34(7):1208-1214
pubmed: 29186351
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Nat Genet. 2020 Apr;52(4):437-447
pubmed: 32231276
Am J Hum Genet. 1974 Jan;26(1):1-12
pubmed: 4204534
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Cell Discov. 2020 May 4;6:31
pubmed: 32377375
Hum Hered. 2011;72(2):133-41
pubmed: 21996708
Arch Virol. 2015 Oct;160(10):2483-90
pubmed: 26212361
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Nat Commun. 2017 Sep 19;8(1):599
pubmed: 28928442
Nat Commun. 2015 Jan 19;6:5890
pubmed: 25597830
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579